Top Markets
Coin of the day
Sanofi Sanofi

Sanofi

SNY
Ранг среди акций #178
Sanofi, together with its subsidiaries, engages in the research, development,... Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Цена акции
$44.60
Рыночная капитализация
$108.62B
Изменение (1 день)
-1.63%
Изменение (1 год)
-21.62%
Страна
FR
Торговля Sanofi (SNY)

Категория

Выручка компании Sanofi (SNY)
Выручка на Dec 2025 TTM: $54.81B
Согласно последним финансовым отчетам Sanofi, текущая выручка компании (TTM) составляет $54.81B. В 2024 году компания получила выручку $46.08B больше, чем выручке в 2023 году, которая составила $46.01B. Выручка — это общий доход, который компания получает от продажи товаров или услуг. В отличие от прибыли, расходы не вычитаются.
История выручки Sanofi с 2000 по 2026
Выручка на конец каждого года
Год Выручка Изменить
2026 (TTM) $54.81B 0.00%
2025 $54.81B 18.94%
2024 $46.08B 0.16%
2023 $46.01B 5.74%
2022 $43.51B -2.33%
2021 $44.55B -2.12%
2020 $45.51B 7.79%
2019 $42.22B 2.98%
2018 $41.00B -5.67%
2017 $43.46B 19.05%
2016 $36.51B -3.56%
2015 $37.85B -2.23%
2014 $38.72B -10.02%
2013 $43.03B -9.28%
2012 $47.43B 4.51%
2011 $45.38B -0.27%
2010 $45.51B 3.21%
2009 $44.09B 9.79%
2008 $40.16B -5.93%
2007 $42.69B 10.03%
2006 $38.80B 15.26%
2005 $33.66B 57.92%
2004 $21.32B 110.71%
2003 $10.12B 29.32%
2002 $7.82B 35.65%
2001 $5.77B 3.32%
2000 $5.58B 0.00%
Выручка аналогичных компаний или конкурентов
Компания Выручка Разница в выручке Страна
$65.18B 18.92%
US
$58.74B 7.17%
GB
$94.19B 71.85%
US
$61.16B 11.58%
US
$56.15B 2.44%
CH